25.08
Medicare’s GLP-1 pilot program leaves some patients with serious conditions behind
Medicare’s new Bridge program offers GLP-1 weight-loss drugs for $50 a month, but patients with conditions like sleep apnea or Type 2 diabetes are excluded and face much higher costs.